Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-17-000126
Filing Date
2017-07-10
Accepted
2017-07-10 12:32:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G AMENDED MONTHLY FILING - AERI aeri617.txt SC 13G/A 7211
  Complete submission text file 0000053417-17-000126.txt   8835
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Subject) CIK: 0001337553 (see all company filings)

EIN.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87680 | Film No.: 17956982
SIC: 2836 Biological Products, (No Diagnostic Substances)